)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
FamiCord
FamiCord (V3V) investor relations material
FamiCord Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary28 Aug, 2026
Executive summary
Revenue remained stable at EUR 43.2 million in H1 2026, a 0.9% year-over-year decline, despite subdued demand and macroeconomic headwinds.
EBITDA for H1 2026 was EUR 4.3 million, down 13.8% year-over-year, but Q2 showed margin stabilization.
Operating cash flow improved significantly to EUR 3.4 million, driven by working capital improvements and contract mix.
The business model shifted further toward recurring subscription revenue, increasing resilience and predictability.
Net result for H1 2026 was a loss of EUR -1.3 million, with EPS at EUR -0.08, reflecting higher costs and weaker financial results.
Financial highlights
Sales revenue: EUR 43.2 million in H1 2026 (down 0.9% year-over-year).
EBITDA: EUR 4.3 million (down 13.8% year-over-year); EBITDA margin 9.9% (down from 11.4%).
Gross profit: EUR 25.0 million (down from EUR 27.0 million year-over-year).
Net income: EUR -1.3 million (down from EUR -0.1 million in H1 2025); EPS EUR -0.08.
Cash and cash equivalents: EUR 12.4 million as of June 30, 2026, up 4.8% since year-end 2025.
Outlook and guidance
Full-year 2026 revenue expected between EUR 80–90 million; EBITDA guidance EUR 9–11 million.
Weak economic environment anticipated to persist, with no signs of quick recovery.
Management anticipates further agreements in CDMO and explores growth in adjacent areas.
Cost control and liquidity management remain priorities.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from FamiCord
- Revenue and EBITDA declined, but recurring revenues and cash flow showed resilience.V3V
Q1 2026 - Revenue and EBITDA rose, but net income and cash flow declined amid rising uncertainties.V3VQ4 2025
- Revenue and EBITDA rose, recurring contracts increased, and 2025 outlook is confirmed.V3VQ3 2025
- 2024 revenue guidance set at €85–95M, with strong growth and new product rollouts in key markets.V3VStatus Update
- Eastern Europe and acquisitions drive strong revenue and EBITDA growth, with focus on core business.V3VQ2 2025
- EBITDA surged 77.5% to €6.4M, with revenue up 6.3% and guidance reaffirmed.V3VQ3 2024
- Revenue and EBITDA rose sharply, with robust renewals and a new CAR-T license agreement.V3VQ2 2024
- Revenue up 6.6%, EBITDA up 58%, but net loss widened on goodwill impairments; growth outlook positive.V3VQ4 2024
- Strong revenue and EBITDA growth offset by currency and inflation headwinds; guidance reaffirmed.V3VQ1 2025
Next FamiCord earnings date
Q3 202630 Nov, 2026
FamiCord
Next FamiCord earnings date
Q3 202630 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
FamiCord AG engages in the collection, preparation, cryopreservation, and storage of stem cells from umbilical cord blood and tissue in Europe. The company also manufactures and sells reagents for bone marrow diagnostics. Its products include frozen cord blood units, partal bio-banking, culture and expansion f IMR90 K1, hematopoietic stem cells, adult progenitor cells, endothelial progenitor cells Mitomycin C; Vitapur; Vitafrost; Vitastem ampoules; sweet-hand sterilization bags for various applications; freezing bag for ten freezing bags; and pipette with tips. The company was founded in 1997 and is headquartered in Leipzig, Germany.